Neuropeptide Y as Alternative Pharmacotherapy for Antidepressant-Resistant Social Fear

In many social anxiety disorder (SAD) patients, the efficacy of antidepressant therapy is unsatisfactory. Here, we investigated whether mice deficient for the lysosomal glycoprotein acid sphingomyelinase (ASM−/−) represent an appropriate tool to study antidepressant-resistant social fear. We also in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kornhuber, Johannes, Zoicas, Iulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662288/
https://www.ncbi.nlm.nih.gov/pubmed/33153050
http://dx.doi.org/10.3390/ijms21218220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662288/
https://www.ncbi.nlm.nih.gov/pubmed/33153050
http://dx.doi.org/10.3390/ijms21218220

Ejemplares similares